NRX Pharmaceuticals Earnings Preview
Portfolio Pulse from Benzinga Insights
NRX Pharmaceuticals (NASDAQ:NRXP) is scheduled to release its quarterly earnings report on March 28, 2024, with analysts expecting an EPS of $-0.07. The company's past performance shows a pattern of beating EPS estimates, leading to positive share price movements the following day. However, shares have declined 27.21% over the last 52 weeks, indicating long-term shareholder dissatisfaction. Investors will be keenly watching for not only the earnings results but also the company's guidance for future growth.
March 27, 2024 | 5:01 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
NRX Pharmaceuticals is expected to report an EPS of $-0.07 for the upcoming quarter. Historical data shows positive stock movement following earnings beats. However, the stock has experienced a significant decline over the past year.
Given NRX Pharmaceuticals' history of beating EPS estimates and the subsequent positive impact on its stock price, there's potential for short-term price appreciation if the trend continues. However, the overall negative performance over the past year suggests that long-term concerns may still weigh on the stock. The company's future guidance will be crucial in determining the stock's direction in the short term.
CONFIDENCE 80
IMPORTANCE 90
RELEVANCE 100